Pichai says AlphaGenome 2 helps uncover cellular drivers of disease
Briefing by News4U · First published
Today Google CEO Sundar Pichai said on X that AlphaGenome 2 is helping uncover the cellular drivers of disease, giving scientists a powerful tool to predict how DNA variants impact specific cell types. He said every cell shares the same DNA blueprint, but different cell types read it differently, and that the new Google DeepMind model predicts how specialized cells interpret DNA, making it significantly easier to link genetic findings to the root causes of disease in the cells where they unfold. He also said AlphaGenome 2 is available today for non-commercial research via the AlphaGenome API. Google DeepMind said the model was trained on 100M+ profiles across 68 tissues and spots nearly twice as many mutations that turn genes on and off as the previous model. [1] [2] [3]
Sources
- @sundarpichai (X): AlphaGenome 2 is helping uncover the cellular drivers of disease, giving scientists a powerful tool to predict how DNA variants impact speci
@sundarpichai (X) · · Excerpt
- @sundarpichai (X): AlphaGenome 2 is available today for non-commercial research via the AlphaGenome API
@sundarpichai (X) · · Excerpt
- @googledeepmind (X): Trained on 100M+ profiles across 68 tissues, AlphaGenome 2 focuses on one cell type at a time, spotting nearly twice as many mutations that
@googledeepmind (X) · · Excerpt